A Good Response to Nivolumab in a Patient with Heavily Pre-treated <i>KRAS</i> Mutant Invasive Mucinous Adenocarcinoma

Haigan(2017)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要